nach oben

Erschienen in:

01.12.2013 | Incidence study

Incretin mimetics: pancreatitis identified in daily clinical practice

Erschienen in: Reactions Weekly | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

There is an association between incretin-mimetic therapy and pancreatic damage, according to an article recently published in Expert Opinion on Drug Safety. Incretin mimetics, such as exenatide, bind to the glucagon-like peptide-1 receptor, stimulating glucose independent insulin release for patients with type 2 diabetes mellitus (T2DM). …

Incretin-mimetics associated pancreatitis: evidence from the spontaneous adverse drug reactions reporting in Italy. Expert Opinion on Drug Safety : [6 pages], 13 Nov 2013. Available from: URL: http://dx.doi.org/10.1517/14740338.2014.853036

Titel: Incretin mimetics: pancreatitis identified in daily clinical practice
Publikationsdatum: 01.12.2013
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2013
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-7688-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Carboplatin/erlotinib/gemcitabine

Adalimumab

Doxorubicin

Heparin

Antineoplastics

Darunavir/ritonavir